Trinity Biotech plc (TRIB)
NASDAQ: TRIB · Real-Time Price · USD
0.7045
+0.0186 (2.70%)
At close: Aug 1, 2025, 4:00 PM
0.7084
+0.0040 (0.56%)
After-hours: Aug 1, 2025, 6:22 PM EDT
Trinity Biotech Employees
Trinity Biotech had 401 employees as of December 31, 2024. The number of employees increased by 21 or 5.53% compared to the previous year.
Employees
401
Change (1Y)
21
Growth (1Y)
5.53%
Revenue / Employee
$153,504
Profits / Employee
-$79,274
Market Cap
13.08M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 401 | 21 | 5.53% |
Dec 31, 2023 | 380 | -18 | -4.52% |
Dec 31, 2022 | 398 | -79 | -16.56% |
Dec 31, 2021 | 477 | -66 | -12.15% |
Dec 31, 2020 | 543 | -36 | -6.22% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
TRIB News
- 9 days ago - Trinity Biotech Unveils CGM+: An AI-Native Platform Targeting the $260 Billion AI Wearable Market - GlobeNewsWire
- 4 weeks ago - Trinity Biotech Reaches Profitability Inflection Point, Marking Major Milestone in Strategic Turnaround - GlobeNewsWire
- 5 weeks ago - Trinity Biotech Secures Key Regulatory Approval for Offshored and Outsourced Manufacturing of Its Flagship Rapid HIV Test, Accelerating Strategic & Financial Performance Transformation - GlobeNewsWire
- 2 months ago - Trinity Biotech Publishes Fourth Quarter and Fiscal Year 2024 Financial Results & Provides a Business Update - GlobeNewsWire
- 5 months ago - Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Global Select Requirement for Minimum Market Value of Publicly Held Shares and Nasdaq Minimum Bid Price Requirement - GlobeNewsWire
- 5 months ago - Trinity Biotech Further Strengthens Focus on Continuous Glucose Monitoring – Appoints Barclays to Advise on Ongoing Strategic Realignment Process - GlobeNewsWire
- 5 months ago - Trinity Biotech Announces Additional Funding To Support Transformation Plan & Continued Development of the Company's Continuous Glucose Monitoring Technology - GlobeNewsWire
- 6 months ago - Trinity Biotech Reports Landmark First-Day Accuracy Gains in CGM Pre-Pivotal Trial - GlobeNewsWire